Phase II study of combination therapy with docetaxel, cisplatin, and S-1 (DCS) for advanced gastric cancer: (KDOG 0601)

被引：0
|
作者：
Nakayama, N.
Koizumi, W.
Sasaki, T.
Tanabe, S.
Nishimura, K.
Higuchi, K.
Takagi, S.
Katada, C.
Azuma, M.
Saigenji, K.
机构：
[1] Kanagawa Canc Ctr, Yokohama, Kanagawa 2410815, Japan
[2] Kitasato Univ, East Hosp, Sagamihara, Kanagawa 228, Japan
[3] Kitasato Univ Hosp, Sagamihara, Kanagawa, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4555
引用
收藏
页数：2
相关论文
共 50 条
  • [31] A multicenter phase II study of combination therapy with oral S-1 plus cisplatin in elderly patients with advanced gastric cancer.
    Terazawa, Tetsuji
    Iwasa, Satoru
    Sasaki, Yusuke
    Okazaki, Shunsuke
    Goto, Masahiro
    Kojima, Yasushi
    Naganuma, Atsushi
    Nagashima, Kengo
    Hirano, Hidekazu
    Honma, Yoshitaka
    Takashima, Atsuo
    Kato, Ken
    Hamaguchi, Tetsuya
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [32] Phase II study of modified docetaxel, cisplatin and S-1 (mDCS) combination chemotherapy in patients with unresectable metastatic gastric cancer
    Sato, Y.
    Ohnuma, H.
    Okamoto, K.
    Miyamoto, H.
    Hirakawa, M.
    Uemura, N.
    Kikuchi, S.
    Sagawa, T.
    Fujikawa, K.
    Takahashi, Y.
    Minami, S.
    Okuda, T.
    Takahashi, M.
    Kato, J.
    Takayama, T.
    ANNALS OF ONCOLOGY, 2017, 28
  • [33] Conversion therapy for inoperable advanced gastric cancer patients by docetaxel, cisplatin, and S-1 (DCS) chemotherapy: a multi-institutional retrospective study
    Yasushi Sato
    Hiroyuki Ohnuma
    Takayuki Nobuoka
    Masahiro Hirakawa
    Tamotsu Sagawa
    Koshi Fujikawa
    Yasuo Takahashi
    Minami Shinya
    Shinich Katsuki
    Minoru Takahashi
    Masahiro Maeda
    Yutaka Okagawa
    Uemura Naoki
    Syouhei Kikuch
    Koichi Okamoto
    Hiroshi Miyamoto
    Mitsuo Shimada
    Takemasa Ichiro
    Junji Kato
    Tetsuji Takayama
    Gastric Cancer, 2017, 20 : 517 - 526
  • [34] A phase I study of bi-weekly combination therapy with S-1 and docetaxel for advanced or recurrent gastric cancer
    Rino, Y
    Takanashi, Y
    Yukawa, N
    Saeki, H
    Wada, H
    Kanari, M
    Yamada, R
    Satoh, T
    Yamamoto, N
    Imada, T
    ANTICANCER RESEARCH, 2006, 26 (2B) : 1455 - 1462
  • [35] Phase II study of cetuximab plus S-1/cisplatin therapy in Japanese patients with advanced gastric cancer
    Yamaguchi, Kensei
    Fuse, Nozomu
    Komatsu, Yoshito
    Fujii, Hirofumi
    Hironaka, Shuichi
    Omuro, Yasushi
    Muro, Kei
    Yasui, Hirofumi
    Ueda, Shinya
    Nishina, Tomohiro
    Watanabe, Morihiro
    Ohtsu, Atsushi
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2021, 51 (06) : 879 - 885
  • [36] Phase II study of docetaxel, oxaliplatin and S-1 (DOS) for patients with advanced gastric cancer
    Zang, D.
    Kang, Y.
    Ryu, B.
    Ryu, M.
    Lee, S.
    Kim, H.
    Kim, J.
    Jung, J.
    Kwon, J.
    Kim, H.
    EJC SUPPLEMENTS, 2009, 7 (02): : 375 - 375
  • [37] A Randomized Phase 2 Study of Docetaxel and S-1 Versus Docetaxel and Cisplatin in Advanced Gastric Cancer With an Evaluation of SPARC Expression for Personalized Therapy
    Jeung, Hei-Cheul
    Rha, Sun Young
    Im, Chong Kun
    Shin, Sang Joon
    Ahn, Joong Bae
    Yang, Woo Ick
    Roh, Jae Kyung
    Noh, Sung Hoon
    Chung, Hyun Cheol
    CANCER, 2011, 117 (10) : 2050 - 2057
  • [38] A Phase I/II Study of NAC with Docetaxel, Cisplatin, and S-1 for Stage III Gastric Cancer
    Tanaka, Yusaku
    Kunisaki, Chikara
    Izumisawa, Yusuke
    Makino, Hirochika
    Kimura, Jun
    Sato, Sho
    Miyamoto, Hiroshi
    Kosaka, Takashi
    Ono, Hidetaka A.
    Takahashi, Masazumi
    Sato, Kei
    Akiyama, Hirotoshi
    Endo, Itaru
    ANTICANCER RESEARCH, 2018, 38 (10) : 6015 - 6021
  • [39] Phase I study of S-1 and biweekly docetaxel combination chemotherapy for advanced and recurrent gastric cancer
    Takahashi, I
    Emi, Y
    Kakeji, Y
    Tokunaga, E
    Ushiro, S
    Oki, E
    Watanabe, M
    Baba, H
    Maehara, Y
    ONCOLOGY REPORTS, 2006, 15 (04) : 849 - 854
  • [40] Phase I study of S-1, docetaxel and cisplatin combination chemotherapy in patients with unresectable metastatic gastric cancer
    T Takayama
    Y Sato
    T Sagawa
    T Okamoto
    H Nagashima
    Y Takahashi
    H Ohnuma
    G Kuroiwa
    K Miyanishi
    R Takimoto
    T Matsunaga
    J Kato
    K Yamaguchi
    K Hirata
    Y Niitsu
    British Journal of Cancer, 2007, 97 : 851 - 856
12345